To Acquire Aadi Subsidiary Inc For $100 Million

Whitehawk Therapeutics

19/12/2024 23:34

Dec 20 (Reuters) - Kaken Pharmaceutical Co Ltd  4521.T :
    * KAKEN PHARMACEUTICAL CO - TO ACQUIRE AADI SUBSIDIARY FOR
$100
MILLION

Source text:  ID:nTSxs83dc2 
Further company coverage:  4521.T